chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Nov2021 at 13:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included mitro-valve prolapse, blood pressure, sulfa allergy and unspecified allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications received within two weeks of vaccination included vitamins (unspecified) for unknown indication, unspecified blood pressure medications and allergy pills; all from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 15:00 (at the age of 53-year-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 15:00 (at the age of 53-year-old); both as single dose for COVID-19 immunisation. The patient experienced arm swollen and painful within minutes on 24Nov2021 at 13:45. The patient experienced fever, chills, inability of body to regulate temperature through 26Nov2021 (reported as Friday) evening. On 27Nov2021, (reported as Saturday), injection site and surrounding area was swollen, red and extremely itchy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, inability of body to regulate temperature was resolved on 26Nov2021, while that of the events arm swollen and painful within minutes, injection site and surrounding area was swollen, red and extremely itchy was not resolved at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.
I tested positive for Covid-19. I had shortness of breath, with a HR of 135 with walking up my stairs. My O2 dropped to 91%.  I am an avid backcountry hiker, so these vitals were not typical. Lots of sinus congestion and sneezing. Sputum production was regular. I had a fever for 4 days straight. I finally didn't get awakened by coughing at night on the night of 10/19/22.
For the second vaccine, I experienced symptoms that were worse than the flu. A few days I did not have energy. I also had brain fog. I found it hard to concentrate. The brain fog lasts a few days. About after a week or two. I was experiencing different things every week. After the second vaccine I decided to get a COVID test. I was worried about the close approximant to others while getting the COVID vaccine. The injection site swelling for 5 days after the second vaccine. I felt like I was having a out of body experience. I also had a lot of pressure behind my eyes. I also ran 101 degree temperature the next morning. I also had little range of motion the next day. I also get quarterly labs done and my HIV labs came back with detectable viral load. Before the vaccines it was not detectable.
Intermittent fever of 99.2-103 degrees for 12 days. Body aches and chills, especially leg pain. Pain in arm at site of injection - felt like a severe pinch that wouldn't go away.
Patient developed afebrile Seizures on 05.23.2008, was diagnosed with Infantile Spasm. Now has Seizure disorder and global developmental delay.  6/29/09 Medical records received DOS 1/15/08 to 8/20/08. Assessment: Infantile spasms, seizures. Patient presents with hypotonia, daily seizure episodes. Fever, cough, difficulty breathing.  7/2/09 Hospital records received DOS 5/23/08 to 6/4/08. Assessment: Infantile spasms, seizures. Patient presented with diarrhea, sudden extension of arms associated with jerky movements, mild hypertension.  8/18/09 ICD-9 codes received: 345.60 Infantile spasms w/o mention of intractable seizures, 787.91 Diarrhea, 780.39 Seizure(s) other.
Upon injecting the shot into her left arm deltoid muscle, I was able to put in some medication and she jumped/moved sideways violently.  She was seated, so she jumped/moved to the right. The rest of the shot squirted on her arm. I am unsure as to how much was actually administered to her. There appeared to be no issues when physically injecting her. Alcohol was administered and the shot was about 2 inches from the acromion process directly to the deltoid muscle. After the injection and pushing in the medication, this is when she jumped/moved to the right.
Child came in for 2nd dose VZV and was given Menactra (Dose 2). Dose one Menactra was 4/4/07
Report 20010018711 describes hives in an 11 year old male who received Engerix-B for prophylaxis of hepatitis B. The vaccine has no known drug allergies and denies having a medical history or taking concomitant medications. On 08/16/2000, the vaccinee received his first dose of Engerix-B. Post-vaccination, on 08/16/2000, he experienced hives and fever. An ER visit was required. the events resolved. On 09/20/2000, the vaccinee received his first done of Recombivax. Post-vaccination on 09/20/2000, he experienced fever and hives. The events resolved. As of 01/23/2001, the outcome of the events is resolved.
Severe Shakes; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Severe Shakes) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced TREMOR (Severe Shakes). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Tremor, at an unspecified dose and frequency. On 25-Feb-2021, TREMOR (Severe Shakes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
This spontaneous report as received from a physician via company representative refers to an unspecified number of patients. On an unknown date the patients may had vaccinated with improperly stored M-M-R II (strength, route, lot number and expiration date not reported). The vaccines were transported in a brown bag. No adverse effects were reported. This is one two reports received from the same reporter (1405USA015828). Additional information has been requested.
Patient began to have changes in smile and when she closed right eye. Right eye would not close completely and right side of mouth would not move. She was treated with prednisolone 1 mg - 5 day treatment.
High blood pressure; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High blood pressure) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (High blood pressure). At the time of the report, HYPERTENSION (High blood pressure) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 15-SEP-2015, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. In 2015, the patient was treated by a physician for a blistering vesicular outbreak and decreased immune symptoms which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX, for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Nurse gave me vaccine too high on arm. Medical facility refuses to tell me the nurses name. Extreme left shoulder pain and loss of range of motion. Scheduled to see orthopedic specialist next week.
Severe flu-like syptoms: Whole body aches, fatigue, low grade fever, chills. Symtoms came on suddenly over approx 10 minute period 11 1/2 hours after injection. Took hot shower, (2) 500ml Aspirin, went to bed. Upon waking at approx 7:30am all symptoms had subsided. No further reactions occured.
Red, swollen, itchy and painful. Size of hive 10 x 11 cm.
This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in left arm on 29Sep2021 14:00 (at the age of 70 years old) (Lot Number: FE3592) as dose 3 (booster), single for covid-19 immunisation. The patient has no medical history. Patient was not pregnant  time of vaccination. Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Patient has no known allergies.  Concomitant medication included regular low dose hormone replacement. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162B2 (lot number: EL9262) and second dose of BNT162B2 (lot number: EN6205) in left arm for covid-19 immunization on an unknown date in 2021 (also reported as 29Sep2021 for both doses). The patient experienced aches, 100.4 (pyrexia), headache, nausea, extreme tiredness, on 30Sep2021 04:00. Reported Event: 100.4, headache, nausea, extreme tiredness, aches, in bed for 18 hours. The patient underwent lab tests and procedures which included body temperature: 100.4 on 30Sep2021. The events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovered in 2021.  Follow-up attempts are completed. No further information is expected.
Diarrhea, nausea & vomiting triggered in response to ingesting food or fluids for 15 days ongoing to date
Patient given 0.5mL instead of the correct dose of 0.3mL. No signs or symptoms reported.
ADACEL given 10-1-08. Pt. was previously vaccinated on 3-8-07
entire head was numb in addition to the top 1/2 of the face; head burning from the inside out and numb; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: wep6955), via an unspecified route of administration in the left arm on 24Mar2021 at 08:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to food, medications, or other products. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 21:00, the patient felt her head burning from inside out and numb. It felt like she was boiling, however, no temperature. The entire head was numb in addition to the top 1/2 of her face. The patient did not receive any treatment for the events burning sensation and numbness facial. The clinical outcomes of the events burning sensation and numbness facial were recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
broke out in whole body rash 3 days after first shot. went to a clinic had to get injection of decadron and script for hydroxyzine pamoate and methylprednisolone. same reaction after second shot, same drugs prescribed. went yet again to same clinic on 5/10/2021 as I broke out again in a whole body rash again, dr prescribed same drug protocol.
Pt recv vax on 11/13/98; 3 hr post vax pt exp shaking, shortness of breath & chills x1 day
This spontaneous report as received from a patient's friend as part of a Market Research for ZOSTAVAX, refers to a 55 year old female patient. Medical history and concurrent conditions were not reported. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (dose, route, lot number and expiration date were not reported). No co-suspect and concomitant therapies were reported. On an unknown date the patient experienced itching on and off for 3 months after received ZOSTAVAX. The outcome of pruritus was reported as recovered/resolved quit sequelae (on an unknown date). The reporter considered pruritus to be related to ZOSTAVAX. Additional information has been requested.
started May 22nd with body aches & pains, then by May 26th it was bad enough to go the the ER, had Bell's Palsy also start on that day. Was given some pain pills & went home. Back to providers office on June 1st and they sent to ER and was admitted to the hospital. Horrible pain everywhere even on the max amount of meds they would give. Went from a fully functioning man to needing 2 people to transfer and couldn't write or cut food. After a few days the figures out it was Guillain Barre Syndrome and started IVIG for 5 days. still in extreme pain everyday. After 14 days was sent to the inpt rehab area to be able to try to learn to walk and get some hand function back. Still am unable to return to work because of hand function and cane usage. need a brace on one foot at all times.
redness; pain; itching; swollen; looked infected, was pretty severe; This spontaneous case was reported by a health care professional and describes the occurrence of INFECTION (looked infected, was pretty severe), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PAIN (pain), VACCINATION SITE PRURITUS (itching) and VACCINATION SITE SWELLING (swollen) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PAIN (pain), VACCINATION SITE PRURITUS (itching) and VACCINATION SITE SWELLING (swollen). In February 2021, the patient experienced INFECTION (looked infected, was pretty severe). At the time of the report, INFECTION (looked infected, was pretty severe), VACCINATION SITE PAIN (pain), VACCINATION SITE PRURITUS (itching) and VACCINATION SITE SWELLING (swollen) had not resolved and VACCINATION SITE ERYTHEMA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patent take lot of medications. Patent take Antibiotic as a Treatment medication
Inappropriate schedule of vaccine administered; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis.  The patient's past medical history included COVID-19 (resolved on an unknown date.) on 12-Nov-2020.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On 02-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). In March 2021, the patient experienced PYREXIA (Low grade fever). At the time of the report, PYREXIA (Low grade fever) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) outcome was unknown.         This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  No concomitant medication information was provided.  No treatment medication was provided.   This case was linked to MOD-2021-621454, MOD-2021-621439 (Patient Link).
arm pain; fever and chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain) and PYREXIA (fever and chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm pain) and PYREXIA (fever and chills). At the time of the report, PAIN IN EXTREMITY (arm pain) and PYREXIA (fever and chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Approximately 18 hrs. after SHINGRIX II vaccination, I experienced "anaphylaxis". My wife is a registered pharmacist who has worked in major hospitals. Felt normal 42hrs. after vaccination.
After 1st dose my left knee in arch had surgery in June 2021 torn meniscus after the booster the next day I was achy tired and headache and body aches and no fever pasted 6 hours. I took Advil. In early Oct2021, I walked up two stairs and there was a pop and I waited and saw my doctor in 22Nov2021 and saw the x-ray and diagnosed as torn meniscus.
Nausea, dizziness, vasovagal syncope (fainting), vomiting
Racing heartbeat (135 bpm) within 5 minutes of receiving vaccine, heart palpitations, weakness
Red sore arm at injection site. Day of vaccine administration. Next day : Headache fever diarrhea and she reports going to doctor. She reports getting a steroid dose in the office and given a script for macrobid 1 cap daily x 5 days and using Tylenol 2 every 4 hours for fever
Pt has two blisters around the injection site that appeared on 11/25/15 (the day after the shot). Pt started itching the morning of 11/27/15 on the upper arm around the injection site. Pt says she is feeling ok, in general. First blister = small 11/25/15 1 AM. Second blister = bigger 11/25/15 10 AM.
Patient called on 11/12/21 and stated she had a very sore arm and it hurt a lot after the vaccine.  She went to a medical facility and was told to contact us.  I called patient and she put her father on a 3 way call.  I explained that some people get a very sore arm after the vaccine.  Patient said that the nurse at the clinic said the vaccine was given "too high."  I did not personally give the vaccine, but all our vaccinators are experienced and well trained.  I reassured the patient and told her to take NSAIDS, ice/heat and give it a few days.  The arm may also be red or have warmth, which is a normal reaction to the vaccine.  Any more serious or lingering side effects should be evaluated by a medical provider.  MD at the medical facility which told her to contact us was informed via phone / email by one of our vaccination coordinators.
minor sore throat; have a minor fever,; some muscle fatigue; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (minor sore throat), PYREXIA (have a minor fever,) and FATIGUE (some muscle fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (minor sore throat), PYREXIA (have a minor fever,) and FATIGUE (some muscle fatigue). At the time of the report, OROPHARYNGEAL PAIN (minor sore throat), PYREXIA (have a minor fever,) and FATIGUE (some muscle fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information provided, No concomitant medication reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
About 45 mins to an hour of receiving the vaccination , i felt  a terrible pounding headache, I took Tylenol ES 500mg after felt relief  but decided to sleep early. When I woke up this morning my injection site arm felt so painful and heavy and i had fevers between 103-101.5 though I took some tylenol 500mg every 6 hours. Tachycardic between 140-120bpm, i still have  terrible headache, muscle & joint pains, extreme fatigue. Some dry cough but no shortness of breath.
The patient was mistakenly administered Pneumovax23 which is not recommended for children under 2 years. Attempts have been made to contact parents, but I have not been able to reach them, so it is unknown if there has been an adverse effect.
Chills; Fatigue; Head congestion/sinus pain; Body aches; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Apr2021 at 16:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Patient had no relevant medical history. Patient previously received penicillin for an unknown indication on an unknown date and experienced allergy. Concomitant medications included cetirizine hydrochloride (ZYRTEC) for an unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 16:30 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 at 16:45, the patient experienced chills, fatigue, head congestion/sinus pain, body aches and dizziness. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care visit. The clinical outcome of the events of chills, fatigue, head pressure, general body pain and dizziness were recovered on an unknown date in 2021.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.